Models of care and NCCN Guideline adherence in very-low-risk prostate cancer

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 11, Issue 11, 2013, Pages 1364-1372

  Aizer, Ayal A ^a   Paly, Jonathan J ^a   Zietman, Anthony L ^a   Nguyen, Paul L ^b   Beard, Clair J ^b   Rao, Sandhya K ^a   Kaplan, Irving D ^c   Niemierko, Andrzej ^a   Hirsch, Michelle S ^b   Wu, Chin Lee ^a   Olumi, Aria F ^a   Michaelson, M Dror ^a   D'Amico, Anthony V ^b   Efstathiou, Jason A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRACHYTHERAPY; CANCER CLASSIFICATION; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CONSULTATION; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MODEL; ONCOLOGY; PHYSICIAN; PRACTICE GUIDELINE; PROSTATE CANCER; PROSTATECTOMY; PROTOCOL COMPLIANCE; RISK ASSESSMENT; RISK FACTOR; TERTIARY CARE CENTER; UNITED STATES; UROLOGY; VERY LOW RISK PATIENT;

AGED; DELIVERY OF HEALTH CARE; DELIVERY OF HEALTH CARE, INTEGRATED; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; REFERRAL AND CONSULTATION; RISK ASSESSMENT; RISK FACTORS;

EID: 84891950825     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2013.0160     Document Type: Article

References (31)

1. Mohler JL, Armstrong AJ, Bahnson RR, et al. NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer, Version 4, 2013. Available at: NCCN.org. Accessed October 2, 2013.
2. Tosoian JJ, Trock BJ, Landis P, et al. Active surveillance program for prostate cancer: an update of the Johns Hopkins experience. J Clin Oncol 2011;29:2185-2190.
3. Hayes JH, Ollendorf DA, Pearson SD, et al. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. JAMA 2010;304:2373-2380.
4. Aizer AA, Paly JJ, Zietman AL, et al. Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer. J Clin Oncol 2012;30:3071-3076.
5. Kasperzyk JL, Shappley WV 3rd, Kenfield SA, et al. Watchful waiting and quality of life among prostate cancer survivors in the physicians' health study. J Urol 2011;186:1862-1867.
6. Eldefrawy A, Katkoori D, Abramowitz M, et al. Active surveillance vs. treatment for low-risk prostate cancer: a cost comparison. Urol Oncol 2013;31:576-580.
7. Corcoran AT, Peele PB, Benoit RM. Cost comparison between watchful waiting with active surveillance and active treatment of clinically localized prostate cancer. Urology 2010;76:703-707.
8. Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994;271:368-374.
9. van den Bergh RC, Roemeling S, Roobol MJ, et al. Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly. Eur Urol 2009;55:1-8.
10. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
11. Actuarial Life Table, 2007. Social Security Administration Web site. Available at: http://www.ssa.gov. Accessed September 23, 2013.
12. Murphy SL,Xu J, Kochanek KD. Deaths: Preliminary Data for 2010. National Vital Statistics Reports 2012;60:1-51. Available at: http://www.cdc.gov/nchs/ data/nvsr/nvsr60/nvsr60-04.pdf. Accessed October 2, 2013.
13. Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008;358:1250-1261.
14. Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 2010;28:1117-1123.
15. Falit BP, Gross CP, Roberts KB. Integrated prostate cancer centers and over-utilization of IMRT: a close look at fee-for-service medicine in radiation oncology. Int J Radiat Oncol Biol Phys 2010;76:1285-1288.
16. Moore MJ, O'Sullivan B, Tannock IF. How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol 1988;6:1736-1745.
17. Fowler FJ Jr, McNaughton Collins M, Albertsen PC, et al. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 2000;283:3217-3222.
18. Visser BC, Ma Y, Zak Y, et al. Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes. HPB (Oxford) 2012;14:539-547.
19. Walz J, Gallina A, Saad F, et al. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol 2007;25:3576-3581.
20. Froehner M, Koch R, Litz RJ, et al. Which patients are at the highest risk of dying from competing causes
21. Feliu J, Jimenez-Gordo AM, Madero R, et al. Development and validation of a prognostic nomogram for terminally ill cancer patients. J Natl Cancer Inst 2011;103:1613-1620.
22. Chow E, Davis L, Panzarella T, et al. Accuracy of survival prediction by palliative radiation oncologists. Int J Radiat Oncol Biol Phys 2005;61:870-873.
23. Korman H, Lanni T Jr, Shah C, et al. Impact of a prostate multidisciplinary clinic program on patient treatment decisions and on adherence to NCCN Guidelines: the William Beaumont Hospital experience. Am J Clin Oncol 2013;36:121-125.
24. Gomella LG, Lin J, Hoffman-Censits J, et al. Enhancing prostate cancer care through the multidisciplinary clinic approach: a 15-year experience. J Oncol Pract 2010;6:e5-10.
25. Litton G, Kane D, Clay G, et al. Multidisciplinary cancer care with a patient and physician satisfaction focus. J Oncol Pract 2010;6:e35-37.
26. Stephenson AJ, Bolla M, Briganti A, et al. Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy. Eur Urol 2012;61:443-451.
27. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2011;364:1708-1717.
28. Wilt TJ, Brawer MK, Jones KM, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012;367:203-213.
29. Widmark A. Prospective randomized trial comparing external beam radiotherapy versus watchful waiting in early prostate cancer. Presented at: Annual Meeting of The American Society of Radiation Oncology; October 3, 2011; Miami, Florida.
30. Klotz L, Zhang L, Lam A, et al. Clinical results of long-term followup of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010;28:126-131.
31. Johansson JE, Andren O, Andersson SO, et al. Natural history of early, localized prostate cancer. JAMA 2004;291:2713-2719.